Login
Home / ENDV : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Endonovo Therapeutics, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
31.88K
AVG Volume
654.08K
Trailing/Forward PE
-0.2/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
02.5K5K7.5K10K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (USD)
-800K-600K-400K-200K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (USD)
-600K-400K-200K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (USD)
-300K-200K-100K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (USD)
-200K0200K400K600K23 Q323 Q424 Q124 Q224 Q324 Q425 Q325 Q426 Q126 Q2
EPS (USD)
-0-0-0-0024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (USD)
-100K0100K200K300KR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (USD)
-2M02M4M6M8MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-10-5051024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
-10000%-7500%-5000%-2500%0%2500%22 Q122 Q222 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q2
Return on Capital
0%1%2%3%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Book Value Per Share (USD)
-0.08-0.06-0.04-0.02023 Q424 Q124 Q224 Q324 Q425 Q125 Q325 Q426 Q126 Q2
Total Assets (USD)
0200K400K600K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Employee Count
05101520201120122013201420152016201720182019
PE Ratio
00.050.10.15med 0.07Apr 24Apr 24May 24May 24May 24Jun 24Jun 24
Free Cash Flow Yield
-500%0%500%1000%med 38.63%Oct 23Jan 24May 24Aug 24Nov 24Mar 25Jun 25
Price to Sales
050100150med 10.83Jan 24Apr 24Aug 24Nov 24Feb 25Jun 25Sep 25
EV/EBITDA
05101520med 15.43Sep 20Dec 20Feb 21Apr 21May 24Jul 24Sep 24
Price/Operating Cashflow
02.557.510med 1.08May 24Jul 24Sep 24Nov 24Feb 25Apr 25Jun 25
Endonovo Therapeutics, Inc.
ENDV
Stockpicker

Video analysis: ENDV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.